- Home
- AXTA vs CORT Comparison
AXTA vs CORT Comparison
Compare AXTA & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXTA
- CORT
- Stock Information
- Founded
- AXTA 1910
- CORT 1998
- Country
- AXTA United States
- CORT United States
- Employees
- AXTA N/A
- CORT N/A
- Industry
- AXTA Paints/Coatings
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- AXTA Consumer Discretionary
- CORT Health Care
- Exchange
- AXTA Nasdaq
- CORT Nasdaq
- Market Cap
- AXTA 6.8B
- CORT 7.1B
- IPO Year
- AXTA 2014
- CORT N/A
- Fundamental
- Price
- AXTA $31.23
- CORT $62.24
- Analyst Decision
- AXTA Buy
- CORT Strong Buy
- Analyst Count
- AXTA 13
- CORT 4
- Target Price
- AXTA $42.54
- CORT $143.25
- AVG Volume (30 Days)
- AXTA 2.4M
- CORT 2.5M
- Earning Date
- AXTA 05-07-2025
- CORT 04-30-2025
- Dividend Yield
- AXTA N/A
- CORT N/A
- EPS Growth
- AXTA 47.33
- CORT 30.85
- EPS
- AXTA 1.78
- CORT 1.23
- Revenue
- AXTA $5,276,000,000.00
- CORT $675,040,000.00
- Revenue This Year
- AXTA $3.41
- CORT $36.81
- Revenue Next Year
- AXTA $3.83
- CORT $32.00
- P/E Ratio
- AXTA $17.54
- CORT $50.60
- Revenue Growth
- AXTA 1.77
- CORT 39.94
- 52 Week Low
- AXTA $27.70
- CORT $20.84
- 52 Week High
- AXTA $41.66
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- AXTA 43.85
- CORT 45.43
- Support Level
- AXTA $27.70
- CORT $65.07
- Resistance Level
- AXTA $31.94
- CORT $71.15
- Average True Range (ATR)
- AXTA 1.53
- CORT 8.92
- MACD
- AXTA 0.09
- CORT -1.67
- Stochastic Oscillator
- AXTA 57.12
- CORT 0.54
About AXTA Axalta Coating Systems Ltd.
Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.